Bookmark

Add to MyYahoo RSS

Covance News

News on Covance (Ticker: CVD) continually updated from thousands of sources around the net.

Monday Aug 18 | Drug Researcher

Top CROs dominate competition in trial totals, review finds

A breakdown of trials run by the top contract research organizations reveals that the big players are leaving little room for smaller firm to compete, according to a review by Outsourcing-Pharma.com of trials in clinicaltrials.gov.

Comment?

Related Topix: Outsourcing, Wilmington, NC, Biotech, Healthcare Industry

Sun Aug 17, 2014

PR-inside.com

New Market Report: Covance Inc. (CVD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Covance Inc. is drug development service company. The company offers a broad range of early-stage and late-stage product development services principally to the pharmaceutical and biotechnology industries.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmacology, Princeton, NJ

Thu Aug 14, 2014

BioSpace

Covance Inc. Partners With To Provide Free Health Care To Wisconsin??'s Uninsured Patients

Covance Inc. , the world's most comprehensive drug development company and a leader in nutritional analysis, partnered with the National Association of Free and Charitable Clinics for a third year to support a day-long clinic where uninsured and underinsured patients in the Madison, Wisconsin, area were given access to free medical attention.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Covance, Madison, WI, Nursing

Thu Jul 31, 2014

AmericanBankingNews.com

Covance Given "Neutral" Rating at SunTrust

's stock had its "neutral" rating reaffirmed by stock analysts at SunTrust in a report issued on Thursday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Covance, Raymond Ltd, Apparel

Drug Researcher

Covance finds early phase work rebound in Q2 as central labs growth continues

The season of quarterly reports is in full swing, with CRO Covance seeing its income and revenue rise in Q2 compared with the same quarter last year due to stronger-than expected early phase development and central labs work.

Comment?

Related Topix: Biotech, Medicine, Covance, Healthcare Industry, Princeton, NJ, Pharmacology

Wed Jul 30, 2014

Seeking Alpha

Covance's (CVD) CEO Joseph Herring on Q2 2014 Results - Earnings Call Transcript

Good day, and welcome to the Covance Second Quarter 2014 Investor Conference Call.

Comment?

Related Topix: Biotech, Medicine, Covance, Healthcare Industry, Pharmacology

Tue Jul 29, 2014

Freshnews

Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639...

Covance Inc. today reported results for its second quarter ended June 30, 2014. Net revenue was $639 million, representing 8.0% growth from the second quarter of 2013.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Covance, Pharmacology

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••